The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 status.

Jiang, Mingxia; Liu, Jiaxuan; Li, Qiao; Xu, Binghe

Jiang, Mingxia; Liu, Jiaxuan; Li, Qiao; Xu, Binghe.

Afiliação

Jiang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Int J Cancer ; 153(7): 1324-1336, 2023 10 01.

Article em En | MEDLINE | ID: mdl-37314204

Assuntos

Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/genética; Neoplasias da Mama/terapia; Neoplasias da Mama/metabolismo; Hibridização in Situ Fluorescente/métodos; Receptor ErbB-2/genética; Receptor ErbB-2/metabolismo; Trastuzumab/uso terapêutico; Prognóstico; Resultado do Tratamento; Amplificação de Genes

Palavras-chave

HER2-low expression; HER2-zero expression; IHC; breast cancer; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google